These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32851912)

  • 1.
    Rolta R; Yadav R; Salaria D; Trivedi S; Imran M; Sourirajan A; Baumler DJ; Dev K
    J Biomol Struct Dyn; 2021 Nov; 39(18):7017-7034. PubMed ID: 32851912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking studies of phytocompounds of
    Rolta R; Salaria D; Kumar V; Patel CN; Sourirajan A; Baumler DJ; Dev K
    J Biomol Struct Dyn; 2022 May; 40(8):3789-3803. PubMed ID: 33225862
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytocompounds of
    Rolta R; Salaria D; Sharma P; Sharma B; Kumar V; Rathi B; Verma M; Sourirajan A; Baumler DJ; Dev K
    Curr Pharmacol Rep; 2021; 7(4):135-149. PubMed ID: 34306988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Suchal K; Handu S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4433-4448. PubMed ID: 32568013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights into the interaction of eighteen different variants of SARS-CoV-2 spike proteins with sixteen therapeutically important phytocompounds: in silico approach.
    Batra B; Srinivasan S; Gopalakrishnan SG; Patel CN; Kumar V; Sourirajan A; Dev K
    J Biomol Struct Dyn; 2023; 41(22):12880-12907. PubMed ID: 36690609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an
    Amin M; Abbas G
    J Biomol Struct Dyn; 2021 Aug; 39(12):4243-4255. PubMed ID: 32469265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease.
    C S; S DK; Ragunathan V; Tiwari P; A S; P BD
    J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an
    Kashyap D; Roy R; Kar P; Jha HC
    J Biomol Struct Dyn; 2023 Jul; 41(10):4770-4785. PubMed ID: 35532092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations.
    Ahamad S; Gupta D; Kumar V
    J Biomol Struct Dyn; 2022 Apr; 40(6):2430-2443. PubMed ID: 33140703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of phyto-compounds as novel inhibitors against
    Kar B; Kundu CN; Pati S; Bhattacharya D
    J Biomol Struct Dyn; 2023 Mar; 41(4):1267-1280. PubMed ID: 34961397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial potential of phytocompounds of
    Shalini K; Guleria S; Salaria D; Rolta R; Fadare OA; Mehta J; Awofisayo O; Mandyal P; Shandilya P; Kaushik N; Choi EH; Chandel SR; Kaushik NK
    J Biomol Struct Dyn; 2024 Mar; 42(5):2726-2737. PubMed ID: 37177811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach.
    Ogidigo JO; Iwuchukwu EA; Ibeji CU; Okpalefe O; Soliman MES
    J Biomol Struct Dyn; 2022 Mar; 40(5):2284-2301. PubMed ID: 33103616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19.
    Swargiary A; Mahmud S; Saleh MA
    J Biomol Struct Dyn; 2022 Mar; 40(5):2067-2081. PubMed ID: 33089730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Malik A; Kohli M; Jacob NA; Kayal A; Raj TK; Kulkarni N; Chandramohan V
    J Biomol Struct Dyn; 2023 Jan; 41(1):221-233. PubMed ID: 34844519
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2024; 21(3):73-89. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Therapeutic Potential of
    Ali MA; Sheikh H; Yaseen M; Faruqe MO; Ullah I; Kumar N; Bhat MA; Mollah MNH
    Molecules; 2024 May; 29(11):. PubMed ID: 38893400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.